These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12649514)

  • 1. Recommendations for the relationship between sponsors and investigators in the design and conduct of clinical stroke trials.
    Donnan GA; Davis SM; Kaste M;
    Stroke; 2003 Apr; 34(4):1041-5. PubMed ID: 12649514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
    International Liaison Committee on Resuscitation
    Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint recommendations for a total services account as a factor in simplifying contracts.
    Bruns I; Schade-Brittinger C; Wissing F; Ruppert T; Trillsch M
    Ger Med Sci; 2019; 17():Doc10. PubMed ID: 31728135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study.
    Morrow RL; Mintzes B; Gray G; Law MR; Garrison S; Dormuth CR
    Clin Ther; 2022 Mar; 44(3):374-388. PubMed ID: 34955232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. He who pays the piper calls the tune: the role of the industry sponsor in acute stroke trials.
    Bozik M
    Eur Neurol; 2003; 49(2):128-30. PubMed ID: 12584425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scribe of stroke trials.
    van Gijn J
    Eur Neurol; 2003; 49(2):125-7. PubMed ID: 12584424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.
    Fisher M;
    Stroke; 2003 Jun; 34(6):1539-46. PubMed ID: 12750546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis.
    McAlindon TE; Driban JB; Henrotin Y; Hunter DJ; Jiang GL; Skou ST; Wang S; Schnitzer T
    Osteoarthritis Cartilage; 2015 May; 23(5):747-60. PubMed ID: 25952346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical issues during the conduct of clinical trials.
    Silverman H
    Proc Am Thorac Soc; 2007 May; 4(2):180-4; discussion 184. PubMed ID: 17494728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute stroke: trial by jury. The toothless tiger (role of the principal investigator).
    Lees KR; Orgogozo JM
    Eur Neurol; 2003; 49(2):120-4. PubMed ID: 12584423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.
    Schulman KA; Seils DM; Timbie JW; Sugarman J; Dame LA; Weinfurt KP; Mark DB; Califf RM
    N Engl J Med; 2002 Oct; 347(17):1335-41. PubMed ID: 12397192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors.
    Mello MM; Clarridge BR; Studdert DM
    Account Res; 2005; 12(3):163-91. PubMed ID: 16634168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.
    Burdick KE; Ketter TA; Goldberg JF; Calabrese JR
    J Clin Psychiatry; 2015 Mar; 76(3):e342-50. PubMed ID: 25830456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintaining the trust of physicians and the public in the medical literature: report of a task force on scientific publishing of clinical trials.
    Shane E; Civitelli R; Delmas PD; Drezner M; Eisman JA; Lindsay R; Lorenzo J; Miller P; Ralston S; Reid I; Siris E
    J Bone Miner Res; 2007 Nov; 22(11):1661-7. PubMed ID: 17907954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hip osteoarthritis.
    Lane NE; Hochberg MC; Nevitt MC; Simon LS; Nelson AE; Doherty M; Henrotin Y; Flechsenhar K
    Osteoarthritis Cartilage; 2015 May; 23(5):761-71. PubMed ID: 25952347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.